The grant will allow the Study Panel to continue its leadership role in assessing our nation’s biodefense systems, issuing recommendations and advocating for their implementation, and informing policymakers and lawmakers on viable avenues for needed change.
The Blue Ribbon Study Panel on Biodefense released its report, A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts, in October 2015. The report identifies capability gaps and recommends changes to U.S. policy and law to strengthen national biodefense while optimizing resource investments.
The panel is cochaired by former Sen. Joe Lieberman and former Gov. Tom Ridge, who are joined by former Secretary of Health and Human Services Donna Shalala, former Sen. Tom Daschle, former Rep. Jim Greenwood, and the Hon. Kenneth Wainstein. Hudson Institute, the Inter-University Center for Terrorism Studies, and the Potomac Institute for Policy Studies are the Panel’s institutional sponsors.
“The deadly anthrax attacks took place just days after my arrival in Washington to head up Homeland Security in the wake of 9/11,” said Gov. Tom Ridge, the first U.S. Secretary of Homeland Security and co-chair of the Blue Ribbon Study Panel on Biodefense. “Fifteen years later, it is troubling that we still do not have a comprehensive approach to preparing for and responding to biological events. That is why this grant from Open Philanthropy is so critical. It will allow us to push forward the recommendations detailed in our National Blueprint and seek to put them into action.”
The Open Philanthropy Project identifies outstanding giving opportunities, makes grants, follows the results, and publishes its findings. Its mission is to give as effectively as it can and share the findings openly so that anyone can build on them.
“Biological threats are among the most important risks to our safety and security,” said Jaime Yassif, Program Officer for Biosecurity and Pandemic Preparedness at the Open Philanthropy Project. “Strengthening US biodefense capacity is a critical issue that requires sustained attention by Congress and the Executive Branch. We are delighted to support the Blue Ribbon Study Panel on Biodefense and the leadership role they are taking in this area.”
Sen. Lieberman noted that progress has been made since the Panel presented its findings last fall. Before Congress recessed, the Senate Committee on Homeland Security and Governmental Affairs passed Chairman Ron Johnson’s National Biodefense Strategy Act of 2016. The bill, the product of a major recommendation by the Panel, now awaits action by the full Senate.
Additionally, Senator Joni Ernst successfully attached that bill to the Senate’s National Defense Authorization Act for Fiscal Year 2017. The House has comparable language in its own defense authorization bill. Sen. Lieberman said it is incumbent on the two chambers to conference and send a defense authorization bill, complete with a National Biodefense Strategy provision, to the President.